Cearvol Wave vs Otofonix Encore

The Cearvol Wave is a budget-priced OTC hearing aid with a visible in-ear style, earning a B grade with a SoundScore of 3.9/5 in our lab testing. At $397, it ranks #22 among 65 OTC hearing aids tested, placing it in the top 32% of its category. This device demonstrates notable strengths in music streaming, scoring 4.1/5—a strong result that sits 2.18 points above the OTC category average. Speech performance is solid in quiet environments at 3.1/5, measuring 0.36 points above average. Speech in noise scores 2.0/5, which is above the category average by 0.56 points, though this remains a mixed result in absolute terms. The Cearvol Wave shows some trade-offs in other areas. Own-voice comfort scores 2.1/5, falling 0.41 points below the category average—a consideration for those sensitive to how their own voice sounds while wearing hearing aids. Feedback handling measures 3.8/5, which is solid in absolute terms, though it sits 0.74 points below the typically strong OTC category average for this metric. The Cearvol Wave is best suited for budget-conscious consumers who prioritize music streaming quality and want solid speech clarity in quieter settings. Those who frequently encounter noisy environments or are particularly sensitive to own-voice quality may want to consider alternatives.

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.